Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue - OtherRevenue - Rental
Ratios

Maxcyte (MXCT) Other Gross PP&E Adjustments (2020 - 2025)

Historic Other Gross PP&E Adjustments for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $3.7 million.

  • Maxcyte's Other Gross PP&E Adjustments fell 487.11% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 487.11%. This contributed to the annual value of -$6.6 million for FY2024, which is 1441.25% down from last year.
  • Maxcyte's Other Gross PP&E Adjustments amounted to $3.7 million in Q3 2025, which was down 487.11% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Maxcyte's Other Gross PP&E Adjustments peaked at $5.0 million during Q3 2023, and registered a low of -$6.6 million during Q4 2024.
  • In the last 5 years, Maxcyte's Other Gross PP&E Adjustments had a median value of $3.4 million in 2021 and averaged $1.3 million.
  • As far as peak fluctuations go, Maxcyte's Other Gross PP&E Adjustments plummeted by 397480.39% in 2021, and later surged by 73122.52% in 2023.
  • Over the past 5 years, Maxcyte's Other Gross PP&E Adjustments (Quarter) stood at -$4.0 million in 2021, then surged by 66.96% to -$1.3 million in 2022, then crashed by 339.89% to -$5.7 million in 2023, then fell by 14.41% to -$6.6 million in 2024, then surged by 155.56% to $3.7 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $3.7 million for Q3 2025, versus $3.4 million for Q2 2025 and $3.2 million for Q1 2025.